SEC Form 4 · accession 0000950142-15-001092
MELINTA THERAPEUTICS, INC. /NEW/ · MLNT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Dov A Goldstein M.D.
Director
Period of report
May 14, 2015
Accepted (ET)
May 18, 2015 · 5:19 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001461993
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | May 14, 2015 | J | 1,099,950 | $0.00 | D | 2,193,110 | I | By Aisling Capital II, LP |
| Common Stock | holding | — | — | — | 50 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1On May 14, 2015, Aisling Capital II, LP ("Aisling") distributed 1,100,000 shares of Common Stock (the "Shares") of Cempra, Inc. (the "Issuer") to its general and limited partners on a pro-rata basis. Of the 1,100,000 Shares distributed by Aisling, Aisling Capital Partners, LP ("Aisling GP") received its pro-rata interest of 11,000 Shares, which it immediately distributed to its general and limited partners, including Dr. Goldstein, who received (and now directly holds) his pro-rata interest, consisting of 50 Shares.
- F2The reportable securities are owned directly by Aisling, and held indirectly by Aisling GP, as general partner of Aisling, and Aisling Capital Partners, LLC ("Aisling Partners"), as general partner of Aisling GP. Dr. Goldstein is a member of the investment committee of Aisling. Dr. Goldstein disclaims beneficial ownership of these securities and this report is not an admission that he is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of his pecuniary interest therein.